Terminated NA INTERVENTIONAL 2-arm NCT00787462

Evaluation of Pregabalin in Idiopathic Small Fiber Neuropathy

Sponsor: Capital Health, Canada

Updated 7 times since 2017 Last updated: Aug 24, 2017 Started: Feb 29, 2008 Primary completion: Feb 28, 2013 Completion: Feb 28, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Restrictive inclusion criteria/limited pool of suitable subjects with SFN.

Other terminated trials from Capital Health, Canada

Fatigue · Phase PHASE3 · Feb 2019

More terminations from Capital Health, Canada

A NA clinical study on Small-Fiber Neuropathy, this trial is terminated or withdrawn. The trial is conducted by Capital Health, Canada and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Sep 2017 — Jun 2018 [monthly]

Terminated NA

Status: Suspended → Terminated

▶ Show 2 earlier versions

Aug 2017 — Sep 2017 [monthly]

Suspended NA
Jan 2017 — Aug 2017 [monthly]

Suspended NA

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Capital Health, Canada
University of Alberta

Data source: University of Alberta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edmonton, Canada